{"id":"fe50c7b2-e074-5ca2-abd4-9f2339cf2101","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:nattokinase-raises-clot-lysis-further-with-pai-1-present","predicate":"increases","statement":"At the same 1 nM and with active PAI-1 present, the same enzyme enhanced tPA-induced clot lysis by 78 +/- 2.0%.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"98ab5f54-6c62-5988-af72-387f11b0b333","mechanism_event_label":"At the same 1 nM and with active PAI-1 present, the same enzyme enhanced tPA-induced clot lysis by 78 +/- 2.0%.","subject":{"id":"6b03a125-209a-5060-8b35-ec9e0e54033c","slug":"nattokinase","display_name":"Nattokinase / subtilisin NAT","entity_type_key":"peptide"},"object":{"id":"5cd37c4b-a4ba-5c44-8a18-3c9a8ddfb2dc","slug":"tpa-induced-clot-lysis","display_name":"Tissue-plasminogen-activator-induced fibrin clot lysis in vitro","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"98ab5f54-6c62-5988-af72-387f11b0b333","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:nattokinase-raises-clot-lysis-further-with-pai-1-present-event","event_type":"biochemical_relationship","label":"At the same 1 nM and with active PAI-1 present, the same enzyme enhanced tPA-induced clot lysis by 78 +/- 2.0%.","description":"tPA-induced clot lysis, active recombinant PAI-1 present","status":"provisional","compartment":null,"participants":[{"entity":{"id":"6b03a125-209a-5060-8b35-ec9e0e54033c","slug":"nattokinase","display_name":"Nattokinase / subtilisin NAT","entity_type_key":"peptide"},"role":"acting component","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"5cd37c4b-a4ba-5c44-8a18-3c9a8ddfb2dc","slug":"tpa-induced-clot-lysis","display_name":"Tissue-plasminogen-activator-induced fibrin clot lysis in vitro","entity_type_key":"cellular_process"},"role":"component the finding is about","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"duration","value_text":"Not stated here","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"In vitro fibrin clot system","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Subtilisin NAT, 1 nM","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The stronger enhancement when PAI-1 is present is the evidence for a second, inhibitor-directed arm. It is one assay in one laboratory.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"organism","value_text":"In vitro fibrin clot system","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"At the same 1 nM and with active PAI-1 present, the same enzyme enhanced tPA-induced clot lysis by 78 +/- 2.0%.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis Cleaves and inactivates plasminogen activator inhibitor type 1. (2001) https://pubmed.ncbi.nlm.nih.gov/11325965/ DOI: 10.1074/jbc.M101751200","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vitro","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"tPA-induced clot lysis, active recombinant PAI-1 present","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"c5f7f61f-b230-5909-a2ca-498c02be1af2","evidence_kind":"source_excerpt","locator":"Lines 158-158","start_line":158,"end_line":158,"excerpt":"At the same 1 nM and with active PAI-1 present, the same enzyme enhanced tPA-induced clot lysis by 78 +/- 2.0%.","model_system":"In vitro fibrin clot system","directness":"reported_statement","verification_status":"source_derived_draft","notes":"","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"41cb127c-1c23-53aa-b7d0-5ec7f6fa3c99","stable_key":"import-33bef151-bdc7-5892-aff6-0345ab149739","title":"Nattokinase: what the purified enzyme cleaves, what survives being eaten, and the gap between the two (2026-09-23)","document_type":"imported_text","citation_label":"Original AI-assisted curation built from a supplied entity-first document of 105 entities and 129 claims. Every reference in that document was resolved against live PubMed with its abstract read and its DOI cross-checked on 2026-09-23, and the EFSA novel-food opinion was retrieved and read in full. That check corrected two PMIDs that pointed at unrelated papers, two DOIs, and two papers recorded as carrying no erratum that do carry one; it also reversed three findings the supplied document had stated backwards. Two papers carry a published correction, recorded as such and not as a retraction. Three sources are not indexed in PubMed and are cited by what they have. Laboratory lineages are recorded, so the four papers from one group, the three from another and the two readings of a single applicant dossier cannot be counted as separate lines of support. Study-specific doses, units, populations and limitations retained; activity units are never converted between systems. Not publisher full text.","file_path":"","sha256":"34fc46e0e849d06bfa13cb099a79b50679dd6fd0de8a5a0575326afdde3259c1","revision_id":"efd063e6-e982-5f6e-a4b8-6f2ffe4185ce","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}